AGP Picks
View all

Insufflation devices market seen reaching $4.16 billion by 2030

3 hours ago
By AI, Created 15:48 UTC, Aug 12, 2026, AGP -

The Business Research Company says the global insufflation devices market is on track to grow from $3.14 billion in 2026 to $4.16 billion by 2030, driven by more minimally invasive surgeries, rising obesity rates and expanded healthcare infrastructure. North America leads the market now, while Asia-Pacific is expected to grow fastest.

Why it matters: - Insufflation devices are used in minimally invasive surgeries to inflate body cavities, improve visibility and give surgeons more working space. - Growth in this market tracks broader demand for laparoscopic and other less invasive procedures, which can reduce patient trauma and improve recovery. - The market’s expansion also points to rising spending on surgical technology as hospitals and outpatient centers modernize.

What happened: - The Business Research Company released an updated insufflation devices market report on Aug. 12, 2026. - The report puts the market at $3.14 billion in 2026, up from $2.93 billion in 2025. - The company forecasts the market will reach $4.16 billion by 2030. - The report estimates a 7.4% compound annual growth rate from 2025 to 2026 and a 7.3% CAGR through 2030. - North America holds the largest share of the market in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period.

The details: - The report links recent growth to more laparoscopic surgeries, more bariatric and cardiac procedures, wider use of minimally invasive techniques, better surgical infrastructure and more advanced surgical equipment. - The forecast points to stronger demand for high-precision surgical tools, greater focus on patient recovery outcomes, growth in outpatient surgical centers, more single-use insufflation devices and more digital surgical platforms. - The report identifies electronic insufflation systems, disposable devices, pressure and flow monitoring, and improved accuracy and safety as key trends. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - Insufflation devices commonly use carbon dioxide to create the cavity inflation needed during surgery. - The report includes new features such as market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - A free sample and the full report are available through the company’s website: Download a free sample and View the full report.

Between the lines: - Rising obesity levels are expanding demand for bariatric surgery, which relies on insufflation devices for abdominal cavity inflation and better surgical access. - The report cites World Heart Foundation figures showing about 2.3 billion adults and children worldwide were obese or overweight in March 2023, with that number projected to reach 2.7 billion by 2025. - Healthcare infrastructure growth is another major driver, with the report pointing to hospital expansion, chronic disease burden and government efforts to improve access. - The Office for National Statistics said UK healthcare spending rose 5.6% from 2022 to 2023 to about $317.63 billion (£292 billion) in May 2023. - The market’s shift toward disposable devices and digital platforms suggests manufacturers are competing on convenience, precision and safety as much as on surgical performance.

What's next: - The market is expected to keep expanding as more procedures move to minimally invasive settings. - Adoption of electronic insufflation systems and single-use devices is likely to shape product development. - Asia-Pacific’s faster growth may create the next major demand center for surgical equipment suppliers. - The report positions better pressure and flow monitoring as a core product priority going forward.

The bottom line: - Insufflation devices are moving from a niche surgical accessory to a steady-growth global market tied to minimally invasive care, obesity treatment and healthcare buildout.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Middle East Government Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East Government Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.